PreciVax Therapeutics is rated 3 out of 5 in the category biotechnology. Read and write reviews about PreciVax Therapeutics. PreciVax Therapeutics is the first company in HK developing innovative vaccines for drug resistant bacterial infections. Our first product is a vaccine for Methicillin-resistant Staphylococcus aureus (MRSA).
Company size
1-10 employees
Headquarters
Hong Kong, Hong Kong